[Guideline] James AH, Kouides PA, Abdul-Kadir R, et al. Von Willebrand disease and other bleeding disorders in women: consensus on diagnosis and management from an international expert panel. Am J Obstet Gynecol. 2009 Jul. 201(1):12.e1-8. [QxMD MEDLINE Link].
DeCherney A, Polan ML. Hysteroscopic management of intrauterine lesions and intractable uterine bleeding. Obstet Gynecol. 1983 Mar. 61(3):392-7. [QxMD MEDLINE Link].
Chullapram T, Song JY, Fraser IS. Medium-term follow-up of women with menorrhagia treated by rollerball endometrial ablation. Obstet Gynecol. 1996 Jul. 88(1):71-6. [QxMD MEDLINE Link].
Meyer WR, Walsh BW, Grainger DA, et al. Thermal balloon and rollerball ablation to treat menorrhagia: a multicenter comparison. Obstet Gynecol. 1998 Jul. 92(1):98-103. [QxMD MEDLINE Link].
Garza-Leal J, Pena A, Donovan A, et al. Clinical evaluation of a third-generation thermal uterine balloon therapy system for menorrhagia coupled with curettage. J Minim Invasive Gynecol. 2010 Jan-Feb. 17(1):82-90. [QxMD MEDLINE Link]. [Full Text].
Goldrath MH. Evaluation of HydroThermAblator and rollerball endometrial ablation for menorrhagia 3 years after treatment. J Am Assoc Gynecol Laparosc. 2003 Nov. 10(4):505-11. [QxMD MEDLINE Link].
[Guideline] ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 81, May 2007. Obstet Gynecol. 2007 May. 109(5):1233-48. [QxMD MEDLINE Link].
Lethaby A, Hickey M, Garry R. Endometrial destruction techniques for heavy menstrual bleeding. Cochrane Database Syst Rev. 2005 Oct 19. CD001501. [QxMD MEDLINE Link]. [Full Text].
Lentz GM. Abnormal uterine bleeding. Katz VL, Lentz GM, Lobo RA, Gershenson DM, eds. Comprehensive Gynecology. 5th ed. Philadelphia, PA: Mosby; 2007. 915-32.
Chen YJ, Li YT, Huang BS, Y, et al, for the Taiwan Association of Gynecology Systematic Review Group. Medical treatment for heavy menstrual bleeding. Taiwan J Obstet Gynecol. 2015 Oct. 54 (5):483-8. [QxMD MEDLINE Link].
Hallberg L, Nilsson L. Determination of menstrual blood loss. Scand J Clin Lab Invest. 1964. 16:244-8. [QxMD MEDLINE Link].
Goldrath MH. Hysteroscopic endometrial ablation. Obstet Gynecol Clin North Am. 1995 Sep. 22(3):559-72. [QxMD MEDLINE Link].
Fraser IS, Warner P, Marantos PA. Estimating menstrual blood loss in women with normal and excessive menstrual fluid volume. Obstet Gynecol. 2001 Nov. 98(5 Pt 1):806-14. [QxMD MEDLINE Link].
Warner PE, Critchley HO, Lumsden MA, Campbell-Brown M, Douglas A, Murray GD. Menorrhagia I: measured blood loss, clinical features, and outcome in women with heavy periods: a survey with follow-up data. Am J Obstet Gynecol. 2004 May. 190(5):1216-23. [QxMD MEDLINE Link].
Barbara Hoffman, John Schorge, Karen Bradshaw, Lisa Halvorson, Joseph Schaffer, Marlene Corton. Williams Gynecology. 4th. McGraw-Hill Education; 2020.
Collins JA, Schlesselman JJ. Hormone replacement therapy and endometrial cancer. Lobo RA, ed. Treatment of the Postmenopausal Woman: Basic and Clinical Aspects. 2nd ed. Philadelphia, PA: Lippincott, Williams & Wilkins; 1999. 503-12.
Wright RC. Hysterectomy: past, present, and future. Obstet Gynecol. 1969 Apr. 33(4):560-3. [QxMD MEDLINE Link].
Committee on Adolescent Health Care, Committee on Gynecologic Practice. Committee Opinion No.580: von Willebrand disease in women. Obstet Gynecol. 2013 Dec. 122 (6):1368-73. [QxMD MEDLINE Link].
Jones K, Sung S. Anovulatory Bleeding. StatPearls [Internet]. 2022 Jan. [QxMD MEDLINE Link]. [Full Text].
[Guideline] Committee on Practice Bulletins—Gynecology. Practice bulletin no. 128: diagnosis of abnormal uterine bleeding in reproductive-aged women. Obstet Gynecol. 2012 Jul. 120 (1):197-206. [QxMD MEDLINE Link].
James AH. Heavy menstrual bleeding: work-up and management. Hematology Am Soc Hematol Educ Program. 2016 Dec 2. 2016 (1):236-242. [QxMD MEDLINE Link].
Management of Symptomatic Uterine Leiomyomas: ACOG Practice Bulletin, Number 228. Obstet Gynecol. 2021 Jun 1. 137 (6):e100-e115. [QxMD MEDLINE Link].
Management of Endometrial Intraepithelial Neoplasia or Atypical Endometrial Hyperplasia: ACOG Clinical Consensus No. 5. Obstet Gynecol. 2023 Sep 1. 142 (3):735-744. [QxMD MEDLINE Link].
ACOG Committee Opinion No. 651: Menstruation in Girls and Adolescents: Using the Menstrual Cycle as a Vital Sign. Obstet Gynecol. 2015 Dec. 126 (6):e143-e146. [QxMD MEDLINE Link].
Screening and Management of Bleeding Disorders in Adolescents With Heavy Menstrual Bleeding: ACOG COMMITTEE OPINION, Number 785. Obstet Gynecol. 2019 Sep. 134 (3):e71-e83. [QxMD MEDLINE Link].
Wilansky DL, Greisman B. Early hypothyroidism in patients with menorrhagia. Am J Obstet Gynecol. 1989 Mar. 160(3):673-7. [QxMD MEDLINE Link].
Kiran A, Geary RS, Gurol-Urganci I, Cromwell DA, Bansi-Matharu L, Shakespeare J, et al. Sociodemographic differences in symptom severity and duration among women referred to secondary care for menorrhagia in England and Wales: a cohort study from the National Heavy Menstrual Bleeding Audit. BMJ Open. 2018 Feb 2. 8 (2):e018444. [QxMD MEDLINE Link].
Marsh EE, Brocks ME, Ghant MS, Recht HS, Simon M. Prevalence and knowledge of heavy menstrual bleeding among African American women. Int J Gynaecol Obstet. 2014 Apr. 125 (1):56-59. [QxMD MEDLINE Link].
Yu L, Janga B, McAlister R, Jeffe DB, Sonn T. Disparities in Treatment Decisions for Abnormal Uterine Bleeding. J Womens Health (Larchmt). 2021 Oct. 30 (10):1519-1525. [QxMD MEDLINE Link].
Jaafar H, Ismail SY, Azzeri A. Period Poverty: A Neglected Public Health Issue. Korean J Fam Med. 2023 Jul. 44 (4):183-188. [QxMD MEDLINE Link].
Whetstone S, Burke W, Sheth SS, Brooks R, Cavens A, Huber-Keener K, et al. Health Disparities in Uterine Cancer: Report From the Uterine Cancer Evidence Review Conference. Obstet Gynecol. 2022 Apr 1. 139 (4):645-659. [QxMD MEDLINE Link].
ACOG Committee Opinion No. 735: Adolescents and Long-Acting Reversible Contraception: Implants and Intrauterine Devices. Obstet Gynecol. 2018 May. 131 (5):e130-e139. [QxMD MEDLINE Link].
Herman MC, Mol BW, Bongers MY. Diagnosis of heavy menstrual bleeding. Womens Health (Lond). 2016 Jan. 12 (1):15-20. [QxMD MEDLINE Link].
Kadir RA, Economides DL, Sabin CA, et al. Frequency of inherited bleeding disorders in women with menorrhagia. Lancet. 1998 Feb 14. 351(9101):485-9. [QxMD MEDLINE Link].
American College of Obstetricians and Gynecologists' Committee on Practice Bulletins—Gynecology. ACOG Practice Bulletin No. 194: Polycystic Ovary Syndrome. Obstet Gynecol. 2018 Jun. 131 (6):e157-e171. [QxMD MEDLINE Link].
Dodson MG. Use of transvagin*l ultrasound in diagnosing the etiology of menometrorrhagia. J Reprod Med. 1994 May. 39(5):362-72. [QxMD MEDLINE Link].
Dijkhuizen FP, Mol BW, Brolmann HA, Heintz AP. The accuracy of endometrial sampling in the diagnosis of patients with endometrial carcinoma and hyperplasia: a meta-analysis. Cancer. 2000 Oct 15. 89(8):1765-72. [QxMD MEDLINE Link].
The Use of Hysteroscopy for the Diagnosis and Treatment of Intrauterine Pathology: ACOG Committee Opinion, Number 800. Obstet Gynecol. 2020 Mar. 135 (3):e138-e148. [QxMD MEDLINE Link].
Shaw RW. Assessment of medical treatments for menorrhagia. Br J Obstet Gynaecol. 1994 Jul. 101 Suppl 11:15-8. [QxMD MEDLINE Link].
American College of Obstetricians and Gynecologists’ Committee on Clinical Consensus–Gynecology. General Approaches to Medical Management of Menstrual Suppression: ACOG Clinical Consensus No. 3. Obstet Gynecol. 2022 Sep 1. 140 (3):528-41. [QxMD MEDLINE Link]. [Full Text].
Jurema M, Zacur H. Menorrhagia. UpToDate. Available at https://bit.ly/fHJVtw. Accessed: March 29, 2009.
Fraser IS, McCarron G. Randomized trial of 2 hormonal and 2 prostaglandin-inhibiting agents in women with a complaint of menorrhagia. Aust N Z J Obstet Gynaecol. 1991 Feb. 31(1):66-70. [QxMD MEDLINE Link].
Apgar BS, Kaufman AH, George-Nwogu U, Kittendorf A. Treatment of menorrhagia. Am Fam Physician. 2007 Jun 15. 75 (12):1813-9. [QxMD MEDLINE Link].
Committee Opinion No. 602: Depot medroxyprogesterone acetate and bone effects. Obstet Gynecol. 2014 Jun. 123 (6):1398-1402. [QxMD MEDLINE Link].
Committee on Practice Bulletins-Gynecology, Long-Acting Reversible Contraception Work Group. Practice Bulletin No. 186: Long-Acting Reversible Contraception: Implants and Intrauterine Devices. Obstet Gynecol. 2017 Nov. 130 (5):e251-e269. [QxMD MEDLINE Link].
Andersson JK, Rybo G. Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia. Br J Obstet Gynaecol. 1990 Aug. 97(8):690-4. [QxMD MEDLINE Link].
Rauramo I, Elo I, Istre O. Long-term treatment of menorrhagia with levonorgestrel intrauterine system versus endometrial resection. Obstet Gynecol. 2004 Dec. 104(6):1314-21. [QxMD MEDLINE Link].
FDA approves intrauterine device for heavy menstrual bleeding. PR Newswire. Available at https://bit.ly/eKOVjr. 2009 Oct 01; Accessed: October 5, 2009.
Kaunitz AM, Bissonnette F, Monteiro I, Lukkari-Lax E, Muysers C, Jensen JT. Levonorgestrel-releasing intrauterine system or medroxyprogesterone for heavy menstrual bleeding: a randomized controlled trial. Obstet Gynecol. 2010 Sep. 116(3):625-32. [QxMD MEDLINE Link].
[Guideline] ACOG committee opinion no. 557: Management of acute abnormal uterine bleeding in nonpregnant reproductive-aged women. Obstet Gynecol. 2013 Apr (Reaffirmed 2020). 121 (4):891-6. [QxMD MEDLINE Link]. [Full Text].
Lukes AS, Moore KA, Muse KN, et al. Tranexamic acid treatment for heavy menstrual bleeding: a randomized controlled trial. Obstet Gynecol. 2010 Oct. 116(4):865-75. [QxMD MEDLINE Link].
Ray S, Ray A. Non-surgical interventions for treating heavy menstrual bleeding (menorrhagia) in women with bleeding disorders. Cochrane Database Syst Rev. 2016 Nov 10. 11:CD010338. [QxMD MEDLINE Link].
Bofill Rodriguez M, Lethaby A, Grigore M, Brown J, Hickey M, Farquhar C. Endometrial resection and ablation techniques for heavy menstrual bleeding. Cochrane Database Syst Rev. 2019 Jan 22. 1 (1):CD001501. [QxMD MEDLINE Link].
Victoria Lynn Handa, Linda Van Le, Richard W. Te Linde. Te Linde's Operative Gynecology. 12th. Wolters Kluwer; 2020.
Nakamura K, Nakayama K, Sanuki K, Minamoto T, Ishibashi T, Sato E, et al. Long-term outcomes of microwave endometrial ablation for treatment of patients with menorrhagia: A retrospective cohort study. Oncol Lett. 2017 Dec. 14 (6):7783-7790. [QxMD MEDLINE Link].
Nakamura K, Nakayama K, Ishikawa M, et al. Efficacy of multiple microwave endometrial ablation technique for menorrhagia resulting from adenomyosis. J Obstet Gynaecol Res. 2015 Nov. 41 (11):1769-72. [QxMD MEDLINE Link].
Learman LA, Summitt RL Jr, Varner RE, et al. Hysterectomy versus expanded medical treatment for abnormal uterine bleeding: clinical outcomes in the medicine or surgery trial. Obstet Gynecol. 2004 May. 103(5 Pt 1):824-33. [QxMD MEDLINE Link].
Showstack J, Lin F, Learman LA, et al. Randomized trial of medical treatment versus hysterectomy for abnormal uterine bleeding: resource use in the Medicine or Surgery (Ms) trial. Am J Obstet Gynecol. 2006 Feb. 194(2):332-8. [QxMD MEDLINE Link].
Committee Opinion No 701: Choosing the Route of Hysterectomy for Benign Disease. Obstet Gynecol. 2017 Jun. 129 (6):e155-e159. [QxMD MEDLINE Link].
van der Meij E, Emanuel MH. Hysterectomy for heavy menstrual bleeding. Womens Health (Lond). 2016 Jan. 12 (1):63-9. [QxMD MEDLINE Link].
Serres-Cousine O, Kuijper FM, Curis E, Atashroo D. Clinical investigation of fertility after uterine artery embolization. Am J Obstet Gynecol. 2021 Oct. 225 (4):403.e1-403.e22. [QxMD MEDLINE Link].
